华信HXZY品牌怎么样 申请店铺

我要投票 华信HXZY在阿胶行业中的票数:32 更新时间:2024-12-22
华信HXZY是哪个国家的品牌?「华信HXZY」是 山东华信制药集团股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人陆一峰在2002-03-29期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
华信HXZY怎么样

山东华信制药集团创建于2002年3月,总部位于菏泽市高新技术产业园,拥有胶剂、大容量注射剂、片剂、颗粒剂、胶囊剂、口服溶液剂等10个剂型,均一次性顺利通过新版GMP认证。历经风雨十余载,华信集团完成了凤凰涅槃般地美丽蜕变,从一个名不见经传的小厂成长为集科研开发、药品制造、医药经贸于一体的现代化综合性制药集团。

山东华信制药集团自成立以来以“打造民族品牌”为己任,大力发展阿胶产业,加大华信阿胶系列产品的市场开发和拓展,对目标市场进行深耕细作,实施全员营销战略,以阿胶为品牌根基品种,与主要连锁经销商、零售商共同打造百城万家连锁终端市场,抓好终端市场的开发和以省级大区为单位的渠道网络建设,不断推出国食健字阿胶保健品以及阿胶食品,注重阿胶系列产品的规模化运作和规范化经营,实现阿胶全产业链运作,使华信集团向阿胶制品深加工、产业结构多元化、产品系列化、资本收益最大化的格局稳步发展。

华信集团新推出上呼吸道感染主打产品群——独家专利产品、国家三类新药:龙香平喘胶囊、伪麻那敏胶囊、美愈伪麻口服液等产品是公司近两年重点培育的新品种,这也是公司新的经济增长点,在全国的市场营销战略正全面推进,逐步构建以地级市为中心的覆盖各等级医院及社区门诊的销售网络和渠道。以新药龙香平喘胶囊、益中生血胶囊、紫丹活血胶囊、伪麻那敏胶囊、美愈伪麻口服溶液,饮片胶丁为主的临床终端产品正不断刷新销售记录,持续攀升市场占有率,实现终端市场的新突破。

华信制药集团将继续做好产品结构调整,企业转型升级,聚焦主推产品(阿胶、新药),实施大品种、大终端、大健康的发展战略,规范企业运作,建立完善现代企业制度,对接资本市场,建立健全药品全过程的质量控制体系,实行精细化管理,智能化制造,始终如一地追求药品的安全和显著的功能疗效,以实现华信的新腾飞。

Shandong Huaxin Pharmaceutical Group, founded in March 2002, is headquartered in Heze high tech Industrial Park. It has 10 dosage forms including gel, large volume injection, tablet, granule, capsule and oral solution, all of which have successfully passed the new GMP certification at one time. After more than ten years of ups and downs, Huaxin group has completed a beautiful transformation like Phoenix Nirvana, growing from an unknown small factory to a modern comprehensive pharmaceutical group integrating scientific research and development, pharmaceutical manufacturing and pharmaceutical trade. Since its establishment, Shandong Huaxin Pharmaceutical Group has taken "building a national brand" as its own duty, vigorously developed the gelatin industry, increased the market development and expansion of the gelatin series products of Huaxin, deeply cultivated the target market, implemented the marketing strategy of the whole staff, took the gelatin as the basic brand variety, and worked with the main chain dealers and retailers to build a chain terminal market of one hundred cities and ten thousand stores, to make the best of it The development of the end market and the construction of the channel network with the provincial region as the unit, continuously launched the national food Jianzi donkey hide gelatin health products and donkey hide gelatin food, paid attention to the large-scale operation and standardized operation of the donkey hide gelatin series products, realized the operation of the whole industrial chain of donkey hide gelatin, and made Huaxin group steadily distribute to the pattern of the deep processing of donkey hide gelatin products, the diversification of industrial structure, the serialization of products and the maximization of capital gains Exhibition. Huaxin group has newly launched the main product group of upper respiratory tract infection - exclusive patent products, three kinds of national new drugs: Longxiang Pingchuan capsule, pseudoephedrine capsule, Meiyu pseudoephedrine oral liquid and other products, which are the company's key cultivation new varieties in the past two years, which are also the company's new economic growth point. The national marketing strategy is being promoted in an all-round way, and gradually building a coverage centered on prefecture level cities Sales network and channels of all levels of hospitals and community clinics. The clinical terminal products, mainly composed of new drugs Longxiang Pingchuan capsule, Yizhong Shengxue capsule, Zidan Huoxue Capsule, pseudo Ma Namin capsule, Meiyu pseudo Ma oral solution, and decoction pieces Jiaoding, are constantly refreshing their sales records, continuously increasing their market share, and achieving new breakthroughs in the terminal market. Huaxin Pharmaceutical Group will continue to do a good job in product structure adjustment, enterprise transformation and upgrading, focus on the main products (donkey hide gelatin, new drugs), implement the development strategy of large varieties, large terminals and large health, standardize enterprise operation, establish and improve modern enterprise system, connect capital market, establish and improve the quality control system of the whole process of drugs, implement fine management and intelligent manufacturing, and always Such as the pursuit of drug safety and significant functional efficacy, in order to achieve the new take-off of Huaxin.

本文链接: https://brand.waitui.com/9d5f26ed9.html 联系电话:05305923283

千城特选小程序码

7×24h 快讯

新易盛:涉嫌违反限制性规定转让股票等行为 公司实际控制人高光荣被立案调查

新易盛公告,公司控股股东、实际控制人、董事长高光荣于2024年12月20日收到中国证券监督管理委员会签发的《立案通知书》,因“涉嫌违反限制性规定转让股票”等行为被立案调查。该事项现处于调查阶段,具体情况尚待有关部门的最终确认。高光荣因其个人转让股票事宜被立案调查,与公司经营无关,不会对公司产生影响,公司生产经营情况一切正常。公司将持续关注上述事项的进展情况,并严格按照有关法律、法规的规定和要求,及时履行信息披露义务。

2小时前

高德地图首发全域车道级导航

12月21日,蔚来NIO DAY上,高德地图全域车道级导航同蔚来智能电动行政旗舰ET9合作亮相,这也是高德地图车机版首发全域车道级服务,即将在蔚来更多车型得到升级搭载。

2小时前

香港财政司司长陈茂波:香港未来须推动更多跨境合作创新,进一步提升金融市场体量

香港财政司司长陈茂波12月22日在司长随笔中表示,香港未来必须推动更多制度创新、产品创新与跨境合作创新,例如开拓内地通过香港与更多新兴市场的联系,同时巩固好与传统市场的协作,进一步提升香港金融市场的体量、流动性,更好满足科技变革与地缘政局下企业与其他机构的筹融资需要,让香港国际金融中心内涵更丰富、优势更巩固、国际影响力更显著。(界面)

2小时前

湖畔实验室发布2024年创新成果

36氪获悉,12月22日,湖畔实验室(数据科学与应用浙江省实验室)发布包括AI多癌早筛、气象大模型等在内的多项年度创新成果。实验室用前沿AI技术迎战医疗、能源、农业、集成电路等产业难题,部分成果达到国际领先水平,并实现快速的落地应用,构建起“科技+产业”的正循环。作为浙江由民企牵头建设的省实验室,湖畔实验室成立于2020年7月,依托阿里巴巴达摩院建设,聚焦数据科学与应用领域。大会上,湖畔实验室进行了年度教科人一体化优秀项目颁奖和国家级博士后工作站揭牌,并与杭州电子科技大学战略合作签约。

2小时前

卡塔尔警告欧盟,欧盟新指令或致卡方停止向欧盟输送天然气

12月22日,卡塔尔能源事务国务大臣、卡塔尔能源公司总裁兼首席执行官萨阿德·卡比警告,欧盟新指令或导致卡塔尔停止向欧盟输送天然气。卡比说,如果欧盟实施《企业可持续发展尽职调查指令》,让卡塔尔能源公司损失5%的收入,那卡方宁愿不进入欧洲市场。他强调,他不是在虚张声势,因为卡塔尔能源公司的收入属于卡塔尔政府和人民,没有人会接受损失这么多资金。卡比称,欧盟应该对《企业可持续发展尽职调查指令》进行审查。欧盟理事会今年5月批准通过《企业可持续发展尽职调查指令》。该指令将在未来几年分阶段实施,对在欧盟运营的具有一定规模的企业引入强制性的环境尽职调查要求,旨在减轻或终止对环境造成的不利影响。对于违反该指令的企业,最高可被处以全球营业额5%的罚款。

2小时前

本页详细列出关于固本堂的品牌信息,含品牌所属公司介绍,固本堂所处行业的品牌地位及优势。
咨询